Pacific Biosciences Of California Price to Free Cash Flow Ratio 2010-2024 | PACB
Historical price to free cash flow ratio values for Pacific Biosciences Of California (PACB) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pacific Biosciences Of California Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-08 | 1.20 | 0.00 | |
| 2024-12-31 | 1.83 | $-0.74 | 0.00 |
| 2024-09-30 | 1.70 | $-0.90 | 0.00 |
| 2024-06-30 | 1.37 | $-0.98 | 0.00 |
| 2024-03-31 | 3.75 | $-0.95 | 0.00 |
| 2023-12-31 | 9.81 | $-1.06 | 0.00 |
| 2023-09-30 | 8.35 | $-1.11 | 0.00 |
| 2023-06-30 | 13.30 | $-1.16 | 0.00 |
| 2023-03-31 | 11.58 | $-1.28 | 0.00 |
| 2022-12-31 | 8.18 | $-1.25 | 0.00 |
| 2022-09-30 | 5.81 | $-1.14 | 0.00 |
| 2022-06-30 | 4.42 | $-1.02 | 0.00 |
| 2022-03-31 | 9.10 | $-0.82 | 0.00 |
| 2021-12-31 | 20.46 | $-0.57 | 0.00 |
| 2021-09-30 | 25.55 | $-0.47 | 0.00 |
| 2021-06-30 | 34.97 | $-0.43 | 0.00 |
| 2021-03-31 | 33.31 | $-0.50 | 0.00 |
| 2020-12-31 | 25.94 | $0.11 | 245.88 |
| 2020-09-30 | 9.87 | $0.08 | 131.25 |
| 2020-06-30 | 3.45 | $0.09 | 37.30 |
| 2020-03-31 | 3.06 | $0.13 | 24.21 |
| 2019-12-31 | 5.14 | $-0.53 | 0.00 |
| 2019-09-30 | 5.16 | $-0.55 | 0.00 |
| 2019-06-30 | 6.05 | $-0.53 | 0.00 |
| 2019-03-31 | 7.23 | $-0.53 | 0.00 |
| 2018-12-31 | 7.40 | $-0.51 | 0.00 |
| 2018-09-30 | 5.41 | $-0.61 | 0.00 |
| 2018-06-30 | 3.55 | $-0.64 | 0.00 |
| 2018-03-31 | 2.05 | $-0.68 | 0.00 |
| 2017-12-31 | 2.64 | $-0.74 | 0.00 |
| 2017-09-30 | 5.25 | $-0.69 | 0.00 |
| 2017-06-30 | 3.56 | $-0.74 | 0.00 |
| 2017-03-31 | 5.17 | $-0.82 | 0.00 |
| 2016-12-31 | 3.80 | $-0.85 | 0.00 |
| 2016-09-30 | 8.96 | $-0.72 | 0.00 |
| 2016-06-30 | 7.04 | $-0.71 | 0.00 |
| 2016-03-31 | 8.50 | $-0.59 | 0.00 |
| 2015-12-31 | 13.13 | $-0.67 | 0.00 |
| 2015-09-30 | 3.66 | $-0.84 | 0.00 |
| 2015-06-30 | 5.76 | $-0.76 | 0.00 |
| 2015-03-31 | 5.84 | $-0.84 | 0.00 |
| 2014-12-31 | 7.84 | $-0.75 | 0.00 |
| 2014-09-30 | 4.91 | $-0.77 | 0.00 |
| 2014-06-30 | 6.18 | $-0.37 | 0.00 |
| 2014-03-31 | 5.35 | $-0.42 | 0.00 |
| 2013-12-31 | 5.23 | $-0.49 | 0.00 |
| 2013-09-30 | 5.52 | $-0.58 | 0.00 |
| 2013-06-30 | 2.53 | $-1.22 | 0.00 |
| 2013-03-31 | 2.49 | $-1.40 | 0.00 |
| 2012-12-31 | 1.70 | $-1.41 | 0.00 |
| 2012-09-30 | 1.83 | $-1.39 | 0.00 |
| 2012-06-30 | 2.17 | $-1.52 | 0.00 |
| 2012-03-31 | 3.42 | $-1.74 | 0.00 |
| 2011-12-31 | 2.80 | $-2.08 | 0.00 |
| 2011-09-30 | 3.21 | $-14.57 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.339B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.166B | 84.17 |
| Thermo Fisher Scientific (TMO) | United States | $153.961B | 18.62 |
| Alcon (ALC) | Switzerland | $47.401B | 31.51 |
| Edwards Lifesciences (EW) | United States | $44.018B | 28.86 |
| IDEXX Laboratories (IDXX) | United States | $39.134B | 44.97 |
| DexCom (DXCM) | United States | $32.682B | 50.51 |
| IQVIA Holdings (IQV) | United States | $26.521B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.538B | 26.80 |
| STERIS (STE) | Ireland | $22.108B | 25.28 |
| Waters (WAT) | United States | $20.558B | 29.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.317B | 0.00 |
| Hologic (HOLX) | United States | $12.352B | 13.42 |
| Sysmex ADR (SSMXY) | Japan | $11.507B | 0.00 |
| Penumbra (PEN) | United States | $11.201B | 87.92 |
| Globus Medical (GMED) | United States | $9.836B | 22.77 |
| Masimo (MASI) | United States | $8.139B | 30.02 |
| Teleflex (TFX) | United States | $5.395B | 8.90 |
| Glaukos (GKOS) | United States | $5.042B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| TransMedics (TMDX) | United States | $3.241B | 94.86 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| Veracyte (VCYT) | United States | $2.415B | 33.89 |
| LivaNova (LIVN) | United Kingdom | $2.372B | 14.12 |
| Nihon Kohden (NHNKY) | Japan | $2.127B | 11.63 |
| Elekta AB (EKTAY) | Sweden | $1.860B | 16.72 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.483B | 0.00 |
| Artivion (AORT) | United States | $1.212B | 113.52 |
| Pulse Biosciences (PLSE) | United States | $1.123B | 0.00 |
| OPKO Health (OPK) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.989B | 5.26 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.744B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.654B | 14.29 |
| IRadimed (IRMD) | United States | $0.649B | 32.91 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| RxSight (RXST) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| OrthoPediatrics (KIDS) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.469B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.453B | 0.00 |
| NeuroPace (NPCE) | United States | $0.397B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.317B | 6.73 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.58 |
| CVRx (CVRX) | United States | $0.195B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.55 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.29 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.14 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |